Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: “Rock star” researcher awarded $2.4 million to create new skin
Jakub Tolar, the University of Minnesota researcher who shared stage time with Pearl Jam’s Eddie Vedder, has been awarded $2.4 million, by the Schulze Family Foundation, to support his work creating new skin for people suffering from burns and skin diseases, such as epidermolysis bullosa (EB). (Michele De Luca and Graziella Pellegrini are also doing […]
Right Turn: Stem cell books for kids
I have yet to meet a parent who doesn’t think reading to/with their kids is crucial. I’m going to assume that if you’re a scientist, instilling a love of science to your children, through books, is a priority. With winter holidays just around the corner, kids will have lots of time for reading. Whether you’re […]
Right Turn: Making science sexy again
Justin Trudeau, Canada’s “hot” new prime minister, is getting Canadian scientists all worked up – in a good way. For the first time in nearly ten years, the scientific community has a passionate champion in Ottawa ready to undress – sorry unmuzzle – federal scientists and “bring scientific considerations into all aspects of their decision […]
Right Turn: Cancer campaigns
To some people, November is now Movember. That is testament to how successful and pervasive this campaign for men’s health – especially prostate cancer – has become. (Blogger Sara Nolte has also chosen to write about prostate cancer during Movember.) Last month the focus was on breast cancer. The month before that, there were a […]